The ADMA/DDAH pathway regulates VEGF-mediated angiogenesis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 29, Issue 12, 2009, Pages 2117-2124

  Fiedler, Lorna R ^a   Bachetti, Tiziana ^b   Leiper, James ^c   Zachary, Ian ^b   Chen, Lihua ^d   Renné, Thomas ^e   Wojciak Stothard, Beata ^c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF WASHINGTON   (United States)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

ADMA; Angiogenesis; DDAH I; Rho GTPase; VEGF

Indexed keywords

DIMETHYLARGININASE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; RAC1 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ACTIN POLYMERIZATION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL MOTILITY; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVITY; FOCAL ADHESION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UMBILICAL VEIN;

AMIDOHYDROLASES; ANIMALS; APOPTOSIS; ARGININE; CELL ADHESION MOLECULES; CELL POLARITY; CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS; ENDOTHELIAL CELLS; FOCAL ADHESIONS; HUMANS; MICE; MICE, KNOCKOUT; MICROFILAMENT PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROPEPTIDES; NITRIC OXIDE; PHOSPHOPROTEINS; RAC GTP-BINDING PROTEINS; RAC1 GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 73849123495     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.194035     Document Type: Article

References (38)

1. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, Imaizumi T. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation. 1999;99:1141-1146. (Pubitemid 29120084)
2. Vallance P, Leiper J. Cardiovascular biology of the asymmetric dimethy-larginine:dimethylarginine dimethylaminohydrolase pathway. Arte-rioscler Thromb Vasc Biol. 2004;24:1023-1030.
3. Leiper J, Nandi M, Torondel B, Murray-Rust J, Malaki M, O'Hara B, Rossiter S, Anthony S, Madhani M, Selwood D, Smith C, Wojciak-Stothard B, Rudiger A, Stidwill R, McDonald NQ, Vallance P. Disruption of methylarginine metabolism impairs vascular homeostasis. Nat Med. 2007;13:198-1120
4. Cooke JP. NO and angiogenesis. Atheroscler Suppl. 2003;4:53-60.
5. Smith CL, Birdsey GM, Anthony S, Arrigoni FI, Leiper JM, Vallance P. Dimethylarginine dimethylaminohydrolase activity modulates ADMA levels, VEGF expression, and cell phenotype. Biochem Biophys Res Commun. 2003;308:984-989.
6. Kostourou V, Robinson SP, Cartwright JE, Whitley GS. Dimethyl-arginine dimethylaminohydrolase I enhances tumour growth and angio-genesis. Br J Cancer. 2002;87:673-680.
7. Wojciak-Stothard B, Torondel B, Tsang LY, Fleming I, Fisslthaler B, Leiper JM, Vallance P. The ADMA/DDAH pathway is a critical regulator of endothelial cell motility. J Cell Sci. 2007;120:929-942.
8. Konishi H, Sydow K, Cooke JP. Dimethylarginine dimethylaminohy-drolase promotes endothelial repair after vascular injury. J Am Coll Cardiol. 2007;49:1099-1105.
9. Jacobi J, Sydow K, von Degenfeld G, Zhang Y, Dayoub H, Wang B, Patterson AJ, Kimoto M, Blau HM, Cooke JP. Overexpression of dim-ethylarginine dimethylaminohydrolase reduces tissue asymmetric dim-ethylarginine levels and enhances angiogenesis. Circulation. 2005;111: 1431-1438.
10. Murohara T, Asahara T. Nitric Oxide and Angiogenesis in Cardiovascular Disease. Antiox Redox Signal. 2002;4:825-831.
11. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling-in control of vascular function. Nat Rev Mol Cell Biol. 2006; 7:359-371.
12. Ridley AJ. Rho GTPases and cell migration. J Cell Sci. 2001;114: 2713-2722.
13. Hoang MV, Whelan MC, Senger DR. Rho activity critically and selectively regulates endothelial cell organization during angiogenesis. Proc Natl Acad Sci U S A. 2004;101:1874-1879.
14. Bayless KJ, Davis GE. The Cdc42 and Rac1 GTPases are required for capillary lumen formation in three-dimensional extracellular matrices. J Cell Sci. 2002;115:1123-1136.
15. Soga N, Namba N, McAllister S, Cornelius L, Teitelbaum SL, Dowdy SF, Kawamura J, Hruska KA. Rho family GTPases regulate VEGF-stimulated endothelial cell motility. Exp Cell Res. 2001;269:73-87.
16. van Nieuw Amerongen GP, Koolwijk P, Versteilen A, van Hinsbergh VWM. Involvement of RhoA/Rho Kinase Signaling in VEGF-Induced Endothelial Cell Migration and Angiogenesis In Vitro. Arterioscler Thromb Vasc Biol. 2003;23:211-217.
17. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS, Martin GR. A simple, quantitative method for assessing angio-genesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest. 1992;67: 519-528.
18. Zweidinger RA. Photography of bloodstains visualized by luminol. J Forensic Sci. 1973;18:296-302.
19. Wojciak-Stothard B, Torondel B, Zhao L, Renne T, Leiper JM. Modulation of Rac1 activity by ADMA/DDAH regulates pulmonary endothe-lial barrier function. Mol Biol Cell. 2009;20:33-42.
20. Jiang DJ, Jia SJ, Dai Z, Li YJ. Asymmetric dimethylarginine induces apoptosis via p38 MAPK/caspase-3-dependent signaling pathway in en-dothelial cells. J Mol Cell Cardiol. 2006;40:529-539.
21. Goligorsky MS, Abedi H, Noiri E, Takhtajan A, Lense S, Romanov V, Zachary I. Nitric oxide modulation of focal adhesions in endothelial cells. Am J Physiol. 1999;276:C1271-C1281.
22. Zaidel-Bar R, Ballestrem C, Kam Z, Geiger B. Early molecular events in the assembly of matrix adhesions at the leading edge of migrating cells. J Cell Sci. 2003;116:4605-4613.
23. Krause M, Dent EW, Bear JE, Loureiro JJ, Gertler FB. Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol. 2003;19:541-564.
24. Nimnual AS, Taylor LJ, Bar-Sagi D. Redox-dependent downregulation of Rho by Rac. Nat Cell Biol. 2003;5:185-187.
25. Thum T, Tsikas D, Stein S, Schultheiss M, Eigenthaler M, Anker SD, Poole-Wilson PA, Ertl G, Bauersachs J. Suppression of endothelial pro-genitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol. 2005;46:1693-1701.
26. Hasegawa K, Wakino S, Tanaka T, Kimoto M, Tatematsu S, Kanda T, Yoshioka K, Homma K, Sugano N, Kurabayashi M, Saruta T, Hayashi K. Dimethylarginine dimethylaminohydrolase 2 increases vascular endothe-lial growth factor expression through Sp1 transcription factor in endo-thelial cells. Arterioscler Thromb Vasc Biol. 2006;26:1488-1494.
27. Cardounel AJ, Xia Y, Zweier JL. Endogenous methylarginines modulate superoxide as well as nitric oxide generation from neuronal nitric-oxide synthase: differences in the effects of monomethyl-and dimethyl-arginines in the presence and absence of tetrahydrobiopterin. J Biol Chem. 2005;280:7540-7549.
28. Tan W, Palmby TR, Gavard J, Amornphimoltham P, Zheng Y, Gutkind JS. An essential role for Rac1 in endothelial cell function and vascular development. FASEB J. 2008;22:1829-1838.
29. Sawada N, Salomone S, Kim H-H, Kwiatkowski DJ, Liao JK. Regulation of endothelial nitric oxide synthase and postnatal angiogenesis by Rac1. Circ Res. 2008;103:360-368.
30. Connolly JO, Simpson N, Hewlett L, Hall A. Rac regulates endothelial morphogenesis and capillary assembly. Mol Biol Cell. 2002;13: 2474-2485.
31. Garrett TA, Van Buul JD, Burridge K. VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2. Exp Cell Res. 2007;313:3285-3297.
32. Ellerbroek SM, Wennerberg K, Burridge K. Serine phosphorylation negatively regulates RhoA in vivo. J Biol Chem. 2003;278:19023-19031.
33. Ikeda S, Ushio-Fukai M, Zuo L, Tojo T, Dikalov S, Patrushev NA, Alexander RW. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res. 2005;96:467-475.
34. Labrecque L, Royal I, Surprenant DS, Patterson C, Gingras D, Béliveau R. Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. Mol Biol Cell. 2003;14: 334-347.
35. Kraynov VS, Chamberlain C, Bokoch GM, Schwartz MA, Slabaugh S, Hahn KM. Localized Rac activation dynamics visualized in living cells. Science. 2000;290:333-337.
36. Kiosses WB, Shattil SJ, Pampori N, Schwartz MA. Rac recruits high-affinity integrin alphavbeta3 to lamellipodia in endothelial cell migration. Nat Cell Biol. 2001;3:316-320.
37. Schlegel N, Burger S, Golenhofen N, Walter U, Drenckhahn D, Waschke J. The role of VASP in regulation of cAMP-and Rac 1-mediated endo-thelial barrier stabilization. Am J Physiol Cell Physiol. 2008;294: C178-C188.
38. Chen H, Levine YC, Golan DE, Michel T, Lin AJ. Atrial natriuretic peptide-initiated cGMP pathways regulate vasodilator-stimulated phos-phoprotein phosphorylation and angiogenesis in vascular endothelium. J Biol Chem. 2008;283:4439-4447.